vancomycin has been researched along with mdl 63246 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brackman, MA; Dulworth, JK; Kenny, MT | 1 |
| Andreini, BP; Ciabatti, R; Denaro, M; Ferrari, P; Goldstein, BP; Kurz, M; Malabarba, A; Scotti, R | 1 |
2 other study(ies) available for vancomycin and mdl 63246
| Article | Year |
|---|---|
In vitro activity of the semisynthetic glycopeptide amide MDL 63,246.
Topics: Anti-Bacterial Agents; Gram-Positive Cocci; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1995 |
New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Enterococcus; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin; Vancomycin | 1995 |